Facet Biotech
Abbott boosts pipeline with biotech acquisition
March 10, 2010Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab
Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
